» Articles » PMID: 25440757

Does Residing in Urban or Rural Areas Affect the Incidence of Polypharmacy Among Older Adults in Western China?

Overview
Specialty Geriatrics
Date 2014 Dec 3
PMID 25440757
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study is to explore the differences among older adults who are rural or urban residents with respects to their socioeconomic position, chronic health conditions and medication use. This cross-sectional study included 887 community-dwelling older adults (≥60 years) from western China. Trained interviewers collected data from all of the study subjects through face-to-face interviews. Polypharmacy was defined as the concomitant use of five or more medications. A total of 717 participants were included in the study analyses. Compared with their urban counterparts, the older adults in rural China were more likely to have more chronic health conditions, and a lower education level, annual income and insurance coverage rate. In addition, the rural inhabitants were less likely to use medications (58.7% vs. 75.7%, p<0.001). The intensity of medication use (the mean number of drugs) was 1.7 for rural residents and 2.3 for urban residents (p<0.001). The prevalence of polypharmacy was significantly lower in rural residents than urban residents (11.5% vs. 17.5%, p=0.021). Urban residence (odds ratios (OR) 1.89, 95% confidence intervals (CI) 1.03-3.48), number of chronic conditions (OR 1.95, 95% CI 1.16-3.30), diabetes (OR 4.14, 95% CI 2.33-7.37), and cardiovascular disease (CVD) (OR 2.09, 95% CI 1.25-3.51) were positively associated with polypharmacy, whereas good self-rated health (OR 0.32, 95% CI 0.16-0.65) was negatively associated with polypharmacy. In conclusion, urban residence is independently associated with polypharmacy in Chinese elders regardless of chronic health conditions and socioeconomic status.

Citing Articles

Polypharmacy and Elevated Risk of Severe Adverse Events in Older Adults Based on the Korea Institute of Drug Safety and Risk Management-Korea Adverse Event Reporting System Database.

Kim G, Lee J, Jang S, Lee S, Jeon S, Lee S J Korean Med Sci. 2024; 39(28):e205.

PMID: 39048300 PMC: 11263767. DOI: 10.3346/jkms.2024.39.e205.


Sarcopenic obesity in nursing home residents: a multi-center study on diagnostic methods and their association with instrumental activities of daily living.

Tang H, Li R, Li R, Lian R, Chen X, Jiang W BMC Geriatr. 2024; 24(1):446.

PMID: 38773403 PMC: 11110436. DOI: 10.1186/s12877-024-04955-w.


Association between polypharmacy and chronic kidney disease among community-dwelling older people: a longitudinal study in southern China.

Zhang B, Wang J, Liu N, Liu W, Xi R, Wang P BMC Nephrol. 2024; 25(1):169.

PMID: 38760750 PMC: 11100214. DOI: 10.1186/s12882-024-03606-x.


Are there socioeconomic inequalities in polypharmacy among older people? A systematic review and meta-analysis.

Iqbal A, Richardson C, Iqbal Z, OKeefe H, Hanratty B, Matthews F BMC Geriatr. 2023; 23(1):149.

PMID: 36934249 PMC: 10024437. DOI: 10.1186/s12877-023-03835-z.


Risk prediction model of polypharmacy for community-dwelling elderly patients: An assessment tool for early detection.

Tang Q, Lu J, Wu W, Liu Z, Zhao S, Li C Front Pharmacol. 2022; 13:977492.

PMID: 36438819 PMC: 9684720. DOI: 10.3389/fphar.2022.977492.